Emcure Pharmaceuticals Limited has submitted a regulatory disclosure to the National Stock Exchange of India Limited and BSE Limited regarding the cancellation of a scheduled analyst/investor meeting.
The company has cancelled its physical participation in the JM Financial Annual India Conference - India Xchange 2026, which was scheduled for Monday, November 16, 2026, in Mumbai.
The stated reason for the cancellation is "non-availability of the Company's Management."
The company has requested the exchanges to take this information on record as part of regulatory compliance requirements.